RBCN - Rubicon Technology, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
+0.05 (+0.54%)
As of 2:13PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close8.41
Bid8.43 x 1000
Ask8.59 x 1000
Day's Range8.43 - 8.46
52 Week Range7.24 - 9.46
Avg. Volume4,820
Market Cap22.714M
Beta (3Y Monthly)0.55
PE Ratio (TTM)22.25
EPS (TTM)0.38
Earnings DateAug 12, 2019 - Aug 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.75
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago


    Stamford, Connecticut , May 23, 2019 (GLOBE NEWSWIRE) --  Rubicon Technology, Inc. (RBCN) announced today it has acquired certain equipment and assets from a large Indiana based pharmacy operation, including its licenses to operate in 11 states. Rubicon DTP LLC, a newly formed wholly owned subsidiary of Rubicon Technology, will primarily operate this business under the name Direct Dose Rx. Direct Dose Rx is focused on the delivery of prescription medication, over-the-counter drugs and vitamins to skilled nursing facilities and hospitals for patients that are being discharged.

  • GlobeNewswire8 months ago

    Investor Expectations to Drive Momentum within Capital One Financial, Trevena, CVD Equipment, Alpha Pro Tech, Horace Mann Educators, and Rubicon Technology — Discovering Underlying Factors of Influence

    NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • GlobeNewswire8 months ago

    Rubicon Technology Announces $3 Million Stock Repurchase Plan

    Rubicon Technology, Inc. (RBCN) today announced that its Board of Directors has authorized a stock repurchase plan to buy up to $3 million of its common stock from time to time through open market and private transactions.  The timing, price and volume of repurchases will be based upon market conditions, relevant securities laws and other factors. The stock repurchase plan expires on November 19, 2021 and may be terminated at any time. “In our opinion, shares of Rubicon’s common stock are currently trading at a discount to its intrinsic value.